High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.
暂无分享,去创建一个
Hans T. Chung | Liying Zhang | P. Cheung | C. Danjoux | E. Szumacher | L. D'alimonte | G. Morton | A. Deabreu | A. Loblaw | A. Ravi | J. Helou | H. Chung | L. D’Alimonte